Literature DB >> 29866815

Inflammation, von Willebrand factor, and ADAMTS13.

Junmei Chen1, Dominic W Chung1,2.   

Abstract

Increasing evidence indicates that inflammation can cause thrombosis by a von Willebrand factor (VWF)-mediated mechanism that includes endothelial activation, secretion of VWF, assembly of hyperadhesive VWF strings and fibers, cleavage by ADAMTS13, and adhesion and deposition of VWF-platelet thrombi in the vasculature. This mechanism appears to contribute to thrombosis not only in small vessels, but also in large vessels. Inflammation and VWF contribute to atherogenesis and may contribute to arterial and venous thrombosis as well as stroke. Elucidation of the mechanism will hopefully identify new targets and suggest new approaches for prevention and intervention.
© 2018 by The American Society of Hematology.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29866815      PMCID： PMC6043979          DOI： 10.1182/blood-2018-02-769000

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   25.476


  84 in total

1.  Transcriptional regulation of ADAMTS13.

Authors:  Ralf A Claus; Clemens L Bockmeyer; Karim Kentouche; Matthias W Sieber; Volker Oberle; Roland Kaufmann; Hans-Peter Deigner; Wolfgang Lösche
Journal:  Thromb Haemost       Date:  2005-07       Impact factor: 5.249

2.  Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.

Authors:  Chi Young Shim; Ya Ni Liu; Tamara Atkinson; Aris Xie; Ted Foster; Brian P Davidson; Mackenzie Treible; Yue Qi; José A López; Adam Munday; Zaverio Ruggeri; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

3.  Functional self-association of von Willebrand factor during platelet adhesion under flow.

Authors:  Brian Savage; Jan J Sixma; Zaverio M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

4.  von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.

Authors:  A Y Nossent; V VAN Marion; N H VAN Tilburg; F R Rosendaal; R M Bertina; J A VAN Mourik; H C J Eikenboom
Journal:  J Thromb Haemost       Date:  2006-10-16       Impact factor: 5.824

5.  Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.

Authors:  Anyou Wang; Fang Liu; Ningzheng Dong; Zhenni Ma; Jingyu Zhang; Jian Su; Yiming Zhao; Changgeng Ruan
Journal:  Thromb Res       Date:  2010-08-11       Impact factor: 3.944

6.  Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype.

Authors:  Owen J T McCarty; Robert B Conley; Weihui Shentu; Garth W Tormoen; Daogang Zha; Aris Xie; Yue Qi; Yan Zhao; Chad Carr; Todd Belcik; Douglas R Keene; Philip G de Groot; Jonathan R Lindner
Journal:  JACC Cardiovasc Imaging       Date:  2010-09

7.  Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers.

Authors:  Maneesh Arya; Bahman Anvari; Gabriel M Romo; Miguel A Cruz; Jing-Fei Dong; Larry V McIntire; Joel L Moake; José A López
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

8.  A +220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice.

Authors:  J Liu; Y Kanki; Y Okada; E Jin; K Yano; S-C Shih; T Minami; W C Aird
Journal:  J Thromb Haemost       Date:  2009-05-30       Impact factor: 5.824

9.  Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.

Authors:  Junmei Chen; Xiaoyun Fu; Yi Wang; Minhua Ling; Brad McMullen; John Kulman; Dominic W Chung; José A López
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

10.  von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

Authors:  Bing-Qiao Zhao; Anil K Chauhan; Matthias Canault; Ian S Patten; Janie J Yang; Michael Dockal; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2009-08-17       Impact factor: 22.113
View more
  41 in total

1.  ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis.

Authors:  Anne-Sophie Putzer; Hans Worthmann; Gerrit M Grosse; Friedrich Goetz; Jens Martens-Lobenhoffer; Meike Dirks; Jan T Kielstein; Ralf Lichtinghagen; Ulrich Budde; Stefanie M Bode-Böger; Karin Weissenborn; Ramona Schuppner
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

2.  The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen.

Authors:  Laura L Swystun; Kenichi Ogiwara; Jesse D Lai; Juha R M Ojala; Orla Rawley; Fanny Lassalle; Colleen Notley; Olle Rengby; Alison Michels; Kate Nesbitt; Karl Tryggvason; David Lillicrap
Journal:  J Thromb Haemost       Date:  2019-06-20       Impact factor: 5.824

3.  Formation and Resolution of Pial Microvascular Thrombosis in a Mouse Model of Thrombotic Thrombocytopenic Purpura.

Authors:  Reheman Adili; Michael Holinstat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-07-25       Impact factor: 8.311

4.  Recombinant human ADAMTS13 treatment and anti-NET strategies enhance skin allograft survival in mice.

Authors:  Siu Ling Wong; Jeremy Goverman; Caleb Staudinger; Denisa D Wagner
Journal:  Am J Transplant       Date:  2019-12-12       Impact factor: 8.086

5.  Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.

Authors:  Nicoletta Sorvillo; Daniella M Mizurini; Carmen Coxon; Kimberly Martinod; Ronak Tilvawala; Deya Cherpokova; Ari J Salinger; Robert J Seward; Caleb Staudinger; Eranthie Weerapana; Nathan I Shapiro; Catherine E Costello; Paul R Thompson; Denisa D Wagner
Journal:  Circ Res       Date:  2019-06-28       Impact factor: 17.367

6.  Complex Interaction of Platelets, von Willebrand Factor and Leukocytes, in Whole Blood at High Shear Rates Is Mediated by Platelet GPIIb/IIIa Receptor.

Authors:  Yu N Avtaeva; I S Mel'nikov; O S Saburova; K G Guriya; M C Osidak; C P Domogatsky; Z A Gabbasov
Journal:  Bull Exp Biol Med       Date:  2021-10-07       Impact factor: 0.804

Review 7.  Thromboinflammation: From Atherosclerosis to COVID-19.

Authors:  Denisa D Wagner; Lukas A Heger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-07-08       Impact factor: 10.514

8.  Immunohistological Evaluation of Von Willebrand Factor in the Left Atrial Endocardium and Atrial Thrombi from Cats with Cardiomyopathy.

Authors:  Wan-Ching Cheng; Lois Wilkie; Tsumugi Anne Kurosawa; Melanie Dobromylskyj; Simon Lawrence Priestnall; Virginia Luis Fuentes; David J Connolly
Journal:  Animals (Basel)       Date:  2021-04-26       Impact factor: 2.752

9.  Von Willebrand factor as a thrombotic and inflammatory mediator in critical illness.

Authors:  William E Plautz; Zachary A Matthay; Marian A Rollins-Raval; Jay S Raval; Lucy Z Kornblith; Matthew D Neal
Journal:  Transfusion       Date:  2020-06-01       Impact factor: 3.157

Review 10.  Illustrated State-of-the-Art Capsules of the ISTH 2020 Congress.

Authors:  Sriram Krishnaswamy; Walter Ageno; Yaseen Arabi; Tiziano Barbui; Suzanne Cannegieter; Marc Carrier; Audrey C Cleuren; Peter Collins; Laurence Panicot-Dubois; Jane E Freedman; Kathleen Freson; Philip Hogg; Andra H James; Colin A Kretz; Michelle Lavin; Frank W G Leebeek; Weikai Li; Coen Maas; Kellie Machlus; Michael Makris; Ida Martinelli; Leonid Medved; Marguerite Neerman-Arbez; James S O'Donnell; Jamie O'Sullivan; Madhvi Rajpurkar; Verena Schroeder; Paul Clinton Spiegel; Simon J Stanworth; Laura Green; Anetta Undas
Journal:  Res Pract Thromb Haemost       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.